Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPS62920B2 - - Google Patents
[go: Go Back, main page]

JPS62920B2 - - Google Patents

Info

Publication number
JPS62920B2
JPS62920B2 JP54018225A JP1822579A JPS62920B2 JP S62920 B2 JPS62920 B2 JP S62920B2 JP 54018225 A JP54018225 A JP 54018225A JP 1822579 A JP1822579 A JP 1822579A JP S62920 B2 JPS62920 B2 JP S62920B2
Authority
JP
Japan
Prior art keywords
protein
lauryl sulfate
antibody
tube
sodium lauryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54018225A
Other languages
Japanese (ja)
Other versions
JPS55111788A (en
Inventor
Nobuhiko Nakazawa
Shoichiro Tsushima
Takao Minamizawa
Kazumi Chiba
Seiji Tachibana
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm RI Pharma Co Ltd
Original Assignee
Fujifilm RI Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujifilm RI Pharma Co Ltd filed Critical Fujifilm RI Pharma Co Ltd
Priority to JP1822579A priority Critical patent/JPS55111788A/en
Publication of JPS55111788A publication Critical patent/JPS55111788A/en
Publication of JPS62920B2 publication Critical patent/JPS62920B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明はタンパク固定プラスチツクの製法に関
するものである。 生物学的に活性なタンパク、例えば酵素,抗
体,ホルモンなどを不溶性の担体に固定させたも
のは、その酵素的活性、免疫反応的活性等を利用
するために有用であり、そのためタンパク固定担
体の製造のための種々の方法が公表されている。
例えばハロゲン化シアンで活性化した不溶性多糖
類の担体に共有結合によりタンパクを固定する方
法、グルタルアルデヒド等のジアルデヒド類を架
橋剤としてタンパクを固定する方法、担体の表面
にタンパクを単に物理的に吸着させる方法などが
ある。これらの方法のうち化学的反応によるもの
はCNBrのような危険な試薬を用いる必要があつ
たり、反応操作が複雑で手数がかかる欠点があ
る。また、吸着による方法は操作は簡単である
が、固定されるタンパクの量が充分でなかつた
り、均一に固定できない欠点があり、できたもの
の活性を利用する際バラツキが大きく信頼性が低
く実用的ではなかつた(特公昭45―38543号,特
公昭49―28031号,特公昭51―12712号、特開昭53
―29923号,USP3553310号,USP3646346号各公
報参照)。そこで本発明者は、種々研究の結果、
簡単な操作で均一かつ安定なタンパク固定プラス
チツクを製造する方法を開発した。 本発明は、操作的にはラウリル硫酸塩の存在下
でタンパクとプラスチツク類を接触させるという
吸着法と同程度の簡単なものでよい。 プラスチツク類としては試験管などの材料に用
いられているような合成高分子化合物のものを意
味し、例えばポリエチレン,ポリスチレン,ポリ
プロピレン,シリコンゴム等及びそれらとアクリ
ル酸との共重合体などが適しており、その他にも
前記特開昭53―29923号公報の第5頁にも多くの
例示があるが、ナイロン,ポリカーボネート,ガ
ラスは適さない。この不溶性担体の形状はチユー
ブ状,ビーズ状、シート状またはフイルム状,繊
維状等目的に応じて適宜選ぶことができる。なか
でも試験管の先端を着脱できるようにしたもの
(特開昭53―29923号図面参照)は使用に便利であ
る。 タンパクとしては種々の酵素,抗体,ホルモン
等を挙げることができ、未精製状態または精製し
たものを用いる。タンパクの種類は本発明の性質
上特別な限定が必要ではなくそれぞれ目的に応じ
て選択使用すればよく、分子の大きさがあまり小
さなものは適さないこともあり、一般的には数万
以上の分子量のものが適すと考えられるが、通常
の技術者であれば簡単な予備実験で適否を決定で
きるであろう。この例としては前記特公昭51―
12712号公報第5欄にも記載のあるような蛋白質
分解酵素,脂肪分解酵素,澱粉分解酵素等の消化
系の加水分解酵素その他の分解酵素のような酵素
類があり、一方特開昭53―29923号公報第6頁に
記載のあるような抗体、すなわち各種ステロイド
ホルモン,ペプチドホルモンに対する抗体等各種
の抗体が使用可能である。抗体は抗原を動物に感
作して採血する常法によつて得た抗血清のままで
もよく、硫安による塩析またはアフイニテイクロ
マトグラフイなど常法により精製したものを用い
てもよい。 固定化に際してはラウリル硫酸塩、例えばラウ
リル硫酸ナトリウムおよびタンパクを適当な緩衝
液に溶かしてプラスチツク類と接触させればよ
い。ラウリル硫酸ナトリウムの適当な濃度はタン
パクの種類、精製度合および希釈程度により差が
あるが、一般的には0.001〜0.05%(W/V)好ま
しくは0.003〜0.01%ということができる。接触
させる時の温度は、タンパクを扱うことから加熱
することは好ましくない通常の室温で行なうのが
便利でもあり、良い結果が得られ、その際数時間
乃至10数時間を要するのが普通である。なお、ラ
ウリル硫酸ナトリウムの存在下にタンパクとプラ
スチツクを接触させるとは、三者を同時に加える
ことは勿論、予めプラスチツクをラウリル硫酸ナ
トリウムで処理し、洗浄しまたは洗浄なしに次い
でタンパクと接触させることも含めており、いず
れでも目的は達成できるが、後の実験例では明ら
かとなるように、予めプラスチツクを処理した後
タンパクを接触させるよりも、三者を同時(ラウ
リル硫酸ナトリウムとタンパクの混合液をプラス
チツクに加える)に接触させる方が良い結果が得
られる。予めプラスチツクをラウリル硫酸ナトリ
ウムで処理するときは、このものの濃度はかなり
広い範囲で使用できるがむしろやや濃い方がよ
く、0.01%(W/V)以上0.1%程度が適当であ
り、1.0%でも可能である。タンパク固定プラス
チツクは必要があればポリビニルアルコール溶液
等の安定化剤に浸して被膜を形成させるか或は形
成させることなしに減圧乾燥して保存してもよ
い。 次に抗体をタンパクの例にしてタンパク固定プ
ラスチツクの製造法を示し、その固定化状態をラ
ジオイムノアツセイにより検討した結果を示す
が、本発明はこれらの例によつて限定されるもの
ではない。 ポリエチレンチユーブはエチレン90%とアクリ
ル酸10%の共重合体からなる容量1.1mlの先端部
分を用い、タンパク固定後は筒型の部分と結合し
て使用した。 タンパク固定プラスチツク製造の操作は次のA
法またはB法により、ラジオイムノアツセイ
(RIA)は法,法または法により行なつ
た。 A法 a プラスチツクチユーブを蒸留水で洗浄(30分
間) b 抗体及びラウリル硫酸ナトリウム溶液に接触
(対照は抗体のみ) c 蒸留水で洗浄(5分間×4回) d 1%ポリビニルアルコール溶液に接触(30
分) e 減圧下乾燥 B法 a プラスチツクチユーブを蒸留水で洗浄(30分
間) b ラウリル硫酸ナトリウム溶液に接触(30分
間) c 蒸留水で洗浄(5分間×4回) d 抗体溶液に接触(2時間) e 蒸留水で洗浄(5分間×4回) f 1%ポリビニルアルコール溶液に接触(30分
間) g 減圧下乾燥 法(RIA) a 抗体固定プラスチツクチユーブに標準物質
(緩衝液に溶解)を加える(5μl)。 b 標識抗原(緩衝液に溶解)を加える(1000μ
l)。 c 放置して反応(室温2.5時間) d 内容液を除去 e 生理食塩水でチユーブ内を洗浄(1.5ml×1
回) f チユーブの放射能量をガンマ・カウンターで
測定 法(RIA)(サンドイツチ法) a 抗体固定プラスチツクチユーブに標準物質
0.05Mリン酸緩衝液に溶解)を加える(100μ
l)。 b 0.05Mリン酸緩衝液(0.5%BSA含有)を加
える(400μl)。 c 振盪反応(室温,4時間) d 内容液を除去 e 生理食塩水でチユーブ内を洗浄(1.5ml×1
回) f 標識抗体(0.05Mリン酸緩衝液(0.5%BSA
含有)に溶解)を加える(500μl)。 g 振盪反応(室温,24時間) h 内容液を除去 i 生理食塩水でチユーブ内を洗浄(1.5ml×1
回) j チユーブの放射能量をガンマ・カウンターで
測定 法(RIA) a 抗体固定プラスチツクチユーブに標識抗原溶
液を加える(1ml)。 b 放置して反応(室温,1日) c 内容液を除去 d 生理食塩水でチユーブ内を洗浄(1ml×1
回) e チユーブの放射能量をガンマ・カウンターで
測定 例 1 A法によりポリエチレンチユーブにコルチゾー
ル抗体を固定し、このときの0.003%ラウリル硫
酸ナトリウムの存在による効果を検討した。抗体
はコルチゾール―6α―ヘキサクシネート・
BSAに対する家兎抗血清を硫安で塩析したγG
分画を0.001Mリン酸緩衝液(PH6.4)に溶解して
用いた。RIAは法により行ない標準物質を加え
ないときのカウント(Bo)と総カウント(T)
の比を求めた。標識抗原は6α―カルボキシメチ
ルチオコルチゾール・ヒスタミン−125I(約3万
dpm)を用いた。
The present invention relates to a method for producing protein-fixed plastics. Biologically active proteins, such as enzymes, antibodies, hormones, etc., immobilized on insoluble carriers are useful for utilizing their enzymatic activity, immunoreactive activity, etc. Various methods for manufacture have been published.
For example, a method of immobilizing a protein by covalent bonding to an insoluble polysaccharide carrier activated with cyanogen halide, a method of immobilizing a protein using dialdehydes such as glutaraldehyde as a crosslinking agent, and a method of simply physically immobilizing a protein on the surface of a carrier. There are methods of adsorption. Among these methods, those based on chemical reactions require the use of dangerous reagents such as CNBr, and the reaction operations are complicated and time-consuming. In addition, although the adsorption method is easy to operate, it has the disadvantage that the amount of protein immobilized is not sufficient or cannot be immobilized uniformly, and when the activity of the resulting product is utilized, there is a large variation, making it unreliable and impractical. It was not (Special Publication No. 45-38543, Special Publication No. 28031-1973, Special Publication No. 12712-1971, Japanese Patent Publication No. 53-1973)
―29923, USP3553310, and USP3646346). Therefore, as a result of various studies, the present inventor found that
We have developed a method to produce uniform and stable protein-fixed plastics using simple operations. The present invention may be as simple as an adsorption method in which proteins and plastics are brought into contact in the presence of lauryl sulfate. Plastics refer to synthetic polymer compounds such as those used in materials such as test tubes, such as polyethylene, polystyrene, polypropylene, silicone rubber, and copolymers of these with acrylic acid. Although there are many other examples on page 5 of the above-mentioned Japanese Patent Application Laid-Open No. 53-29923, nylon, polycarbonate, and glass are not suitable. The shape of this insoluble carrier can be appropriately selected depending on the purpose, such as tube, bead, sheet, film, or fiber. Among these, those with removable test tube tips (see drawings in Japanese Patent Application Laid-Open No. 53-29923) are convenient to use. Examples of proteins include various enzymes, antibodies, hormones, etc., and unpurified or purified proteins are used. Due to the nature of the present invention, the type of protein does not need to be particularly limited and can be selected depending on the purpose. It is believed that molecular weight substances are suitable; however, one of ordinary skill in the art will be able to determine suitability through simple preliminary experiments. An example of this is
There are enzymes such as proteolytic enzymes, lipolytic enzymes, starch-degrading enzymes, and other degradative enzymes for the digestive system, as described in column 5 of Publication No. 12712. Various antibodies such as those described in Publication No. 29923, page 6, ie, antibodies against various steroid hormones and peptide hormones, can be used. The antibody may be an antiserum obtained by a conventional method of sensitizing an animal with an antigen and collecting blood, or it may be purified by a conventional method such as salting out with ammonium sulfate or affinity chromatography. For immobilization, lauryl sulfate, such as sodium lauryl sulfate, and protein may be dissolved in a suitable buffer solution and brought into contact with plastics. The appropriate concentration of sodium lauryl sulfate varies depending on the type of protein, degree of purification, and degree of dilution, but is generally 0.001 to 0.05% (W/V), preferably 0.003 to 0.01%. Since we are dealing with proteins, it is not recommended to heat them at room temperature, so it is convenient to do the contact at room temperature, which gives good results, and usually takes several hours to more than 10 hours. . Note that bringing the protein and plastic into contact in the presence of sodium lauryl sulfate means not only adding all three at the same time, but also treating the plastic with sodium lauryl sulfate in advance and washing it or not washing it and then contacting it with the protein. However, as will become clear in later experimental examples, rather than treating the plastic in advance and then contacting the protein, it is better to simultaneously treat the three materials (using a mixture of sodium lauryl sulfate and protein). Better results can be obtained by contacting the plastic (added to plastic). When treating plastics with sodium lauryl sulfate in advance, the concentration of this substance can be used within a fairly wide range, but it is better to use a slightly higher concentration.A value of 0.01% (W/V) or more to 0.1% is appropriate, and 1.0% is also possible. It is. If necessary, the protein-fixed plastic may be stored by soaking it in a stabilizing agent such as a polyvinyl alcohol solution to form a film, or by drying it under vacuum without forming a film. Next, a method for producing a protein-immobilized plastic using an antibody as an example of a protein will be shown, and the results of examining the immobilization state by radioimmunoassay will be shown, but the present invention is not limited to these examples. . The tip of the polyethylene tube was made of a copolymer of 90% ethylene and 10% acrylic acid and had a capacity of 1.1 ml, and after protein fixation, it was used by connecting it to the cylindrical part. The procedure for producing protein-fixed plastics is as follows:
Radioimmunoassay (RIA) was performed according to the Act or B method. Method A a Wash the plastic tube with distilled water (30 minutes) b Contact with antibody and sodium lauryl sulfate solution (control is antibody only) c Wash with distilled water (5 minutes x 4 times) d Contact with 1% polyvinyl alcohol solution ( 30
minutes) e Drying under reduced pressure Method B a Washing the plastic tube with distilled water (30 minutes) b Contacting the sodium lauryl sulfate solution (30 minutes) c Washing with distilled water (5 minutes x 4 times) d Contacting the antibody solution (2 Time) e Washing with distilled water (5 minutes x 4 times) f Contact with 1% polyvinyl alcohol solution (30 minutes) g Drying under reduced pressure (RIA) a Add standard substance (dissolved in buffer solution) to antibody-immobilized plastic tube (5 μl). b Add labeled antigen (dissolved in buffer) (1000μ
l). c Leave to react (2.5 hours at room temperature) d Remove the contents e Wash the inside of the tube with physiological saline (1.5 ml x 1
f) Measuring the amount of radioactivity in the tube using a gamma counter (RIA) (Sand-Germany method) a) Adding the standard material to the antibody-immobilized plastic tube
(dissolved in 0.05M phosphate buffer) and add (100μ
l). b Add 0.05M phosphate buffer (containing 0.5% BSA) (400 μl). c Shaking reaction (room temperature, 4 hours) d Remove the contents e Wash the inside of the tube with physiological saline (1.5 ml x 1
f Labeled antibody (0.05M phosphate buffer (0.5% BSA)
(containing)) (dissolved in) (500 μl). g Shaking reaction (room temperature, 24 hours) h Remove the contents i Wash the inside of the tube with physiological saline (1.5 ml x 1
j) Method for measuring the amount of radioactivity in the tube using a gamma counter (RIA) a) Add the labeled antigen solution to the antibody-immobilized plastic tube (1 ml). b Leave to react (room temperature, 1 day) c Remove the contents d Wash the inside of the tube with physiological saline (1 ml x 1
Example 1: Measurement of the amount of radioactivity in e tubes using a gamma counter Cortisol antibodies were immobilized on polyethylene tubes by Method A, and the effect of the presence of 0.003% sodium lauryl sulfate was investigated. The antibody is cortisol-6α-hexuccinate.
γG salted out with ammonium sulfate from rabbit antiserum against BSA
The fractions were dissolved in 0.001M phosphate buffer (PH6.4) and used. RIA is performed according to the method, and the count (Bo) and total count (T) when no standard substance is added.
The ratio of The labeled antigen is 6α-carboxymethylthiocortisol histamine- 125I (approximately 30,000
dpm) was used.

【表】 この表に見られるように、ラウリル硫酸ナトリ
ウムの存在下抗体とチユーブを接触させた方に標
識抗原が多く結合しており、このことはチユーブ
に抗体も多く固定していることを意味する。ま
た、バラツキも小さく本発明の効果が明らかであ
る。 例 2 A法によりポリエチレンチユーブにTSH抗体
を固定し、ラウリル硫酸ナトリウムの効果を法
のRIAで検討した。抗体は家兎抗ヒトTSH血清を
用い、固定に要した接触時間は2時間である。 結果は図面に示す通りであるが、B320は標準ヒ
トTSH(Carbio Chem.製)を320μU/ml0.1ml
加えたときの測定カウントでありBoは標準物質
なしのときのカウント(非特異的結合量)であ
り、Tは各チユーブに加えた125I―ヒトTSH抗体
(家兎抗ヒトTSH血清をCNBr活性化セフアロー
ス4Bを用いたアフイニテイクロマトグラフイに
より精製し、これをクロラミンT法で125I標識し
たもの)のカウントである。 この図にみられるように、抗血清の希釈程度に
よりラウリル硫酸ナトリウムの最適濃度には幾分
の差がある。ただし、その濃度も0.1%になると
効果がみられなくなる。 例 3 例2と同じ条件でラウリル硫酸ナトリウムと抗
血清を別にして加え、その順序による効果の差を
検討した。
[Table] As seen in this table, more labeled antigen was bound to the tube that was in contact with the antibody in the presence of sodium lauryl sulfate, which means that more antibodies were also immobilized on the tube. do. Moreover, the variation is small and the effect of the present invention is clear. Example 2 A TSH antibody was immobilized on a polyethylene tube using method A, and the effect of sodium lauryl sulfate was examined using RIA using method A. The antibody used was rabbit anti-human TSH serum, and the contact time required for fixation was 2 hours. The results are as shown in the drawing.
Bo is the count measured without the standard substance (non-specific binding amount), and T is the count measured without the standard substance (non-specific binding amount). This is a count of 125 I-labeled chloramine T purified by affinity chromatography using chlorinated Sepharose 4B. As seen in this figure, there are some differences in the optimal concentration of sodium lauryl sulfate depending on the degree of dilution of the antiserum. However, when the concentration reaches 0.1%, no effect is seen. Example 3 Sodium lauryl sulfate and antiserum were added separately under the same conditions as in Example 2, and the difference in effects depending on the order was examined.

【表】 これらの間には顕著な差は認められないが、抗
血清を最後に加える例ではややバラツキが大き
い。 例 4 プラスチツクをラウリル硫酸ソーダ溶液で前処
理し、洗浄した後抗血清を接触させる方法(B
法)とA法を比較した。チユーブはポリエチレン
製で、抗体はTSH抗血清の0.001Mリン酸緩衝液
溶液を用い、RIAは法により行い、標識抗原は
125I標識ヒトTSHを用いた(各群5例)
[Table] Although there is no noticeable difference between these, there is a slight variation in the cases where antiserum is added last. Example 4 A method in which plastic is pretreated with a sodium lauryl sulfate solution, washed, and then contacted with antiserum (B
Method) and Method A were compared. The tube is made of polyethylene, the antibody is a 0.001M phosphate buffer solution of TSH antiserum, RIA is performed by the method, and the labeled antigen is
125 I-labeled human TSH was used (5 cases in each group)

【表】 この結果から、前処理によるB法はA法より劣
るが効果が認められる。 例 6 抗体として家兎抗ヒトTSH血清を用い、これ
をポリエチレンチユーブにA法により固定し法
によりRIAを行ないラウリル硫酸ナトリウムの効
果を検討した。各群5例。
[Table] From this result, method B using pretreatment is inferior to method A, but is recognized to be effective. Example 6 Using rabbit anti-human TSH serum as an antibody, it was immobilized on a polyethylene tube by method A, and RIA was performed by method to examine the effect of sodium lauryl sulfate. 5 cases in each group.

【表】 ラウリル硫酸ナトリウムの存在によりバウンド
の%は高く、バラツキは小さい。 例 7 A法によりポリスチレンチユーブ,ポリプロピ
レンチユーブ及びシリコーン片にTSH抗体を固
定して法によりその効果を検討した(条件等は
例2と同じ)。いずれも数倍の抗体が固定したこ
とが認められバラツキも約1/3になつた。これらの チユーブは、内面を吸着に適すように加工するこ
とにより多くのタンパクを固定できると考えられ
る。 例 8 例7と同様にA法でTSH抗体を固定し、法
で効果を確認することにより、次の界面活性剤
(濃度0.01%)について検討したが、いずれにも
効果が認められなかつた。 ソジウム・オレエート(陰イオン性) ドテシル・トリメチル・アンモニウム・クロリ
ド(陽イオン性) ジメチルアルキルベタイン(アノンBF)(両性
イオン性) ポリオキシエチレンソルビトールモノオレエー
ト(Tween80)(非イオン性)
[Table] Due to the presence of sodium lauryl sulfate, the bound percentage is high and the variation is small. Example 7 A TSH antibody was immobilized on polystyrene tubes, polypropylene tubes, and silicone pieces using Method A, and the effects were examined using the method (the conditions were the same as in Example 2). In all cases, it was observed that several times more antibodies were immobilized, and the variation was reduced to about 1/3. It is thought that it is possible to immobilize a large amount of protein in these tubes by modifying their inner surfaces to make them suitable for adsorption. Example 8 The following surfactants (concentration: 0.01%) were investigated by immobilizing the TSH antibody using Method A in the same manner as in Example 7 and confirming their effects using the method, but no effect was observed with any of them. Sodium oleate (anionic) Dotesyl trimethyl ammonium chloride (cationic) Dimethylalkyl betaine (Anon BF) (zwitterionic) Polyoxyethylene sorbitol monooleate (Tween80) (nonionic)

【図面の簡単な説明】[Brief explanation of the drawing]

図面はラウリル硫酸ナトリウムの濃度とB/Tの
関係を図示したものである。
The figure illustrates the relationship between the concentration of sodium lauryl sulfate and B/T.

Claims (1)

【特許請求の範囲】[Claims] 1 ラウリル硫酸塩の存在下でタンパクとプラス
チツク類を接触させることを特徴とするタンパク
固定プラスチツクの製法。
1. A method for producing protein-fixed plastics, which comprises bringing proteins into contact with plastics in the presence of lauryl sulfate.
JP1822579A 1979-02-19 1979-02-19 Production of protein-fixed plastic Granted JPS55111788A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1822579A JPS55111788A (en) 1979-02-19 1979-02-19 Production of protein-fixed plastic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1822579A JPS55111788A (en) 1979-02-19 1979-02-19 Production of protein-fixed plastic

Publications (2)

Publication Number Publication Date
JPS55111788A JPS55111788A (en) 1980-08-28
JPS62920B2 true JPS62920B2 (en) 1987-01-10

Family

ID=11965699

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1822579A Granted JPS55111788A (en) 1979-02-19 1979-02-19 Production of protein-fixed plastic

Country Status (1)

Country Link
JP (1) JPS55111788A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR245215A1 (en) * 1982-10-06 1993-12-30 Novo Nordisk As Method for production of an immobilized enzyme preparation

Also Published As

Publication number Publication date
JPS55111788A (en) 1980-08-28

Similar Documents

Publication Publication Date Title
US4210418A (en) Container for immunochemical and enzymatical determinations or procedures
US4332783A (en) Process for immunologic determination tests
JP2588274B2 (en) Visual identification of qualitative enzyme assays
CA1215644A (en) Immunoassay for class specific immunoglobulin antibodies
JPS6343711B2 (en)
JPH02156155A (en) Measurement and reagent for specifically bonding substance
JPH0370184B2 (en)
CA1117009A (en) Fc fragment of immunoglobulin bound to a carrier
JPH0543600A (en) Antibody-or antigen-immobilized silk fibroin membrane and sensor for measuring immune
JPH0521510B2 (en)
EP0055751B1 (en) Method for detecting and determining a biological substance by erythroadsorption
JPH08503066A (en) Method of chemical bonding to solid phase
CA1194415A (en) Immunoglobulin half-molecules and process for producing hybrid antibodies
JPH0340830B2 (en)
Pei et al. Enhanced surface plasmon resonance immunoassay for human complement factor 4
JPS62920B2 (en)
JPH01209370A (en) Method and apparatus for measuring immunologically active substance
EP0336647B1 (en) Determination of arachidonic acid derivatives and kits therefore
FR2534030A1 (en) METHOD OF DETECTING AND ASSAYING A BIOLOGICAL SUBSTANCE BY ERYTHROADSORPTION
EP0155252A2 (en) Immunoreactive solid phase
JPH0694716A (en) Immunity measuring method
KR970007080B1 (en) Self-contained multiimmunoassay diagnostic system
CH629894A5 (en) Process for separating the free fractions from the bound fractions in an immunoassay procedure
KR100416490B1 (en) A process for preparing immuno membrane strip
JPS6017358A (en) Analyzing vessel